|
False Claims Act Update & Alert |
||||||
|
Taxpayers
Against Fraud Education Fund | Washington, D.C. |
WWW.TAF.ORG |
||||||
| |
n
TAF Home Page
|
|||||
 IRS
Qui Tam an Early WinnerStephen Whitlock, the head of the new IRS whistleblower office, says his agency has already received cases that are potentially worth hundreds of millions of dollars and that "people who are knowledgeable insiders," are "coming in with big, fat piles of paper." >> To read more |
||||||
 Drug Dealers
Given a PassOxyContin has enslaved scores of thousands of people, many of whom remain in jail for selling or using the drug. Yet officials from Purdue Pharma, the company that illegally marketed OxyContin, will not see jail time and the company itself is free to do business with Medicare and Medicaid. >> To read more |
||||||
 What Value
This Settlement?The
Kansas City, Missouri School District
tried to rip off Uncle Sam for $13.6 million in an E-Rate
program fraud. Their punishment? They have to
pay back $66,000 as a civil settlement.
>>
To read more |
||||||
 Pharma Promotes "Sicko"
Michael Moore's movie "Sicko" premiered in Cannes on Saturday, but not before the Pharmaceutical Research and Manufacturer's Association did its bit to help promote the movie by issuing a press release. >> |
||||||
 Looking
for Fraud In All the Right Places: There are a lot of big False Claims Act cases under investigation. What follows is a quick smattering of major cases we know or suspect due to SEC filings, news articles, or Government reports: 4Nominal Pricing Fraud: Several FCA cases involving violations of the nominal pricing exception have been filed. Possible subjects of these cases involve statins, proton pump inhibitors, and non-steroidal anti-inflammatory drugs. 4Anti-Psychotic Drugs: Investigations about the off-label marketing of Zyprexa, Risperdal and Seroquel are under way. These three drugs represent combined sales of $12 billion in 2006. 4Average Wholesale Price Fraud: The U.S. Government has joined three cases likely to go to trial this summer: Abbott, Dey and Roxane Pharmaceuticals. More than 50 other companies face similar charges in Boston. 4Orthotics Fraud: Ninety percent of the U.S. orthotics industry is under investigation for kickbacks and billing fraud. DePuy, Zimmer, Biomet, Stryker, and Smith & Nephew have combined annual revenues of more than $15 billion. Settlement talks are reportedly nearing conclusion for all but one company. 4PBM Fraud: Caremark and Express Scripts are under investigation for a variety of frauds. Caremark is believed to be in settlement talks. 4University of Phoenix: The Supreme Court has denied certiorari, and the defendants concede they face a billion dollars in liability. 4Outlier Fraud: Several large outlier fraud investigations against hospitals are believed to be under investigation. |
||||||
